Ylva entered the patent profession in 1999. After finishing a Ph.D. at BMC at Uppsala University, she specialized in strategic advising, prosecuting world-wide patent portfolios, life cycle management and litigation. Ylva has been a thought-after advisor for multinational companies, as well as universities and early stage companies, including technology transfer, during over a decade at one of the largest IP firms in Scandinavia.

Ylva has been a long-term part of the team handling international relations, such as the preferred-partner program as well as been responsible for handling international clients. She was long-term member of the management and a board member.

Ylva has helped several companies through IP due diligence in successful private and public financing rounds, and in giving firms advice on license negotiations as well as acquisitions.

She has a solid understanding of the value of IP as a business tool, and clients appreciate her pragmatic approach combined with her extensive experience in handling cases before the European Patent Office and other major and minor patent jurisdictions.

Clients appreciate her commitment, including the ability to understand and communicate complicated technical and legal issues.

Recommended Individual – IAM Patent 1000 2023

Listed in IAM Strategy 300: The World’s Leading IP Strategists 2023



  • European Patent Attorney
  • Authorised Patent Attorney (SE)
  • Ph.D. in medical research, BMC at Uppsala University, Sweden
  • M.Sc. in biology, Hamburg University, Germany


  • Gene therapy
  • Animal genetics
  • Vaccines
  • Diagnostics & prognostic markers
  • Biochemistry
  • Protein pharmaceuticals
  • Food technology
  • Plant genetics and technology
  • Technology transfer & scouting
  • IP value extraction


  • European Patent Institute (EPI)
  • Patentombundsnämnden (SE)